Mounjaro Pens
You may only purchase this item as an existing patient who has been consulted and assessed by the nurse at Lioness Medical.
Mounjaro® contains an FDA approved medication called Tirzepatide.
Tirzepatide is licenced to treat type-2 diabetes and obesity.
Mounjaro® 2.5mg pen contains four doses, which are administered once weekly. Mounjaro® 5mg pen contains 4 weekly doses.
It is a simple injection pen which is self-administered weekly, and pre-filled with the medication. You will also be supplied with the required needles and a sharps bin for disposal of the needles.
